- Report
- January 2022
- 90 Pages
Global
From €1850EUR$2,000USD£1,556GBP
- Report
- January 2022
- 125 Pages
Global
From €2313EUR$2,500USD£1,945GBP
- Report
- January 2022
- 90 Pages
Global
From €1850EUR$2,000USD£1,556GBP
- Report
- April 2020
- 150 Pages
Global
From €6429EUR$6,950USD£5,407GBP
- Report
- January 2025
- 73 Pages
From €3192EUR$3,450USD£2,684GBP
- Report
- April 2024
- 68 Pages
North America
From €3192EUR$3,450USD£2,684GBP
- Report
- March 2024
- 150 Pages
Global
From €4117EUR$4,450USD£3,462GBP
- Report
- February 2024
- 180 Pages
Global
From €4117EUR$4,450USD£3,462GBP
- Report
- January 2024
- 95 Pages
From €3192EUR$3,450USD£2,684GBP
- Report
- January 2024
- 94 Pages
Africa, Middle East
From €3192EUR$3,450USD£2,684GBP
- Report
- November 2023
- 150 Pages
Global
From €4117EUR$4,450USD£3,462GBP
- Report
- November 2023
- 160 Pages
Global
From €4117EUR$4,450USD£3,462GBP
- Report
- March 2023
- 346 Pages
Global
From €4117EUR$4,450USD£3,462GBP
- Report
- February 2023
- 217 Pages
Global
From €4117EUR$4,450USD£3,462GBP
- Report
- January 2023
- 156 Pages
Europe
From €3192EUR$3,450USD£2,684GBP
- Report
- January 2023
- 135 Pages
Middle East, Africa
From €3192EUR$3,450USD£2,684GBP
- Report
- January 2023
- 132 Pages
From €3192EUR$3,450USD£2,684GBP
- Report
- January 2023
- 127 Pages
North America
From €3192EUR$3,450USD£2,684GBP
- Report
- October 2022
- 209 Pages
Global
From €4117EUR$4,450USD£3,462GBP
- Report
- August 2022
- 104 Pages
From €3192EUR$3,450USD£2,684GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more